BioHub At Alderley Park: A Bioincubator With A Difference

Once an R&D site for AstraZeneca, the BioHub at Alderley Park is now home to a number of emerging biotechs. Profiles of Absynth Biologics, Blueberry Therapeutics, Molplex, and OncoTherics.

Deep in the Cheshire countryside in the northwest of England, the Alderley Park BioHub was created by AstraZeneca PLC to support early-stage and growing pharmaceutical and life science companies, allowing them to take advantage of the expertise and high-end facilities on the site.

The BioHub at Alderley Park is owned by Manchester Science Partnerships and managed by BioCity Nottingham Ltd., a bioscience incubator...

More from Archive

More from Scrip